213 related articles for article (PubMed ID: 1550104)
1. Erythromelalgia in thrombocythemia of various myeloproliferative disorders.
Michiels JJ; ten Kate FJ
Am J Hematol; 1992 Feb; 39(2):131-6. PubMed ID: 1550104
[TBL] [Abstract][Full Text] [Related]
2. Erythromelalgia--a thrombotic complication in chronic myeloproliferative disorders.
Tarach JS; Nowicka-Tarach BM; Matuszek B; Nowakowski A
Med Sci Monit; 2000; 6(1):204-8. PubMed ID: 11208311
[TBL] [Abstract][Full Text] [Related]
3. The myeloproliferative disorders. An historical appraisal and personal experiences.
Michiels JJ
Leuk Lymphoma; 1996 Sep; 22 Suppl 1():1-14. PubMed ID: 8951768
[TBL] [Abstract][Full Text] [Related]
4. [Significance of the JAK2V617F mutation in patients with chronic myeloproliferative neoplasia].
Iványi JL; Marton E; Plander M
Orv Hetil; 2011 Nov; 152(45):1795-803. PubMed ID: 22011365
[TBL] [Abstract][Full Text] [Related]
5. Platelet-mediated erythromelalgic, cerebral, ocular and coronary microvascular ischemic and thrombotic manifestations in patients with essential thrombocythemia and polycythemia vera: a distinct aspirin-responsive and coumadin-resistant arterial thrombophilia.
Michiels JJ; Berneman Z; Schroyens W; Koudstaal PJ; Lindemans J; Neumann HA; van Vliet HH
Platelets; 2006 Dec; 17(8):528-44. PubMed ID: 17127481
[TBL] [Abstract][Full Text] [Related]
6. Thrombosis in the Philadelphia Chromosome-Negative Myeloproliferative Neoplasms.
Sankar K; Stein BL; Rampal RK
Cancer Treat Res; 2019; 179():159-178. PubMed ID: 31317487
[TBL] [Abstract][Full Text] [Related]
7. Aspirin for the control of platelet activation and prevention of thrombosis in essential thrombocythemia and polycythemia vera: current insights and rationale for future studies.
Landolfi R; Di Gennaro L; Novarese L; Patrono C
Semin Thromb Hemost; 2006 Apr; 32(3):251-9. PubMed ID: 16673279
[TBL] [Abstract][Full Text] [Related]
8. Platelet-mediated microvascular inflammation and thrombosis in thrombocythemia vera: a distinct aspirin-responsive arterial thrombophilia, which transforms into a bleeding diathesis at increasing platelet counts.
Michiels JJ
Pathol Biol (Paris); 2003 Apr; 51(3):167-75. PubMed ID: 12781799
[TBL] [Abstract][Full Text] [Related]
9. Thrombocythaemic erythromelalgia in chronic myeloproliferative and myelodysplastic disorders.
Michiels JJ; Hagemeyer A; Prins ME
Neth J Med; 1989 Aug; 35(1-2):4-10. PubMed ID: 2779694
[TBL] [Abstract][Full Text] [Related]
10. Platelet consumption in thrombocythemia complicated by erythromelalgia: reversal by aspirin.
van Genderen PJ; Michiels JJ; van Strik R; Lindemans J; van Vliet HH
Thromb Haemost; 1995 Feb; 73(2):210-4. PubMed ID: 7792731
[TBL] [Abstract][Full Text] [Related]
11. Aspirin-responsive, migraine-like transient cerebral and ocular ischemic attacks and erythromelalgia in JAK2-positive essential thrombocythemia and polycythemia vera.
Michiels JJ; Berneman Z; Gadisseur A; Lam KH; De Raeve H; Schroyens W
Acta Haematol; 2015; 133(1):56-63. PubMed ID: 25116182
[TBL] [Abstract][Full Text] [Related]
12. [Erythromelalgia in adults. Apropos of 16 cases].
Levesque H; Cailleux N; Courtois H
Rev Rhum Mal Osteoartic; 1992 Apr; 59(4):258-63. PubMed ID: 1496272
[TBL] [Abstract][Full Text] [Related]
13. Clinical and laboratory features, pathobiology of platelet-mediated thrombosis and bleeding complications, and the molecular etiology of essential thrombocythemia and polycythemia vera: therapeutic implications.
Michiels JJ; Berneman Z; Van Bockstaele D; van der Planken M; De Raeve H; Schroyens W
Semin Thromb Hemost; 2006 Apr; 32(3):174-207. PubMed ID: 16673274
[TBL] [Abstract][Full Text] [Related]
14. Erythromelalgia: a pathognomonic microvascular thrombotic complication in essential thrombocythemia and polycythemia vera.
van Genderen PJ; Michiels JJ
Semin Thromb Hemost; 1997; 23(4):357-63. PubMed ID: 9263352
[TBL] [Abstract][Full Text] [Related]
15. [Histopathologic lesions in erythromelalgia during essential thrombocythemia].
Croue A; Gardembas-Pain M; Verret JL; Boasson M; Rousselet MC; Saint Andre JP
Ann Pathol; 1993; 13(2):128-30. PubMed ID: 8363673
[TBL] [Abstract][Full Text] [Related]
16. Erythromelalgia caused by platelet-mediated arteriolar inflammation and thrombosis in thrombocythemia.
Michiels JJ; Abels J; Steketee J; van Vliet HH; Vuzevski VD
Ann Intern Med; 1985 Apr; 102(4):466-71. PubMed ID: 3977194
[TBL] [Abstract][Full Text] [Related]
17. Megakaryocytic morphology and clinical parameters in essential thrombocythemia, polycythemia vera, and primary myelofibrosis with and without JAK2 V617F.
Vytrva N; Stacher E; Regitnig P; Zinke-Cerwenka W; Hojas S; Hubmann E; Porwit A; Bjorkholm M; Hoefler G; Beham-Schmid C
Arch Pathol Lab Med; 2014 Sep; 138(9):1203-9. PubMed ID: 25171702
[TBL] [Abstract][Full Text] [Related]
18. The gain-of-function JAK2 V617F mutation shifts the phenotype of essential thrombocythemia and chronic idiopathic myelofibrosis to more "erythremic" and less "thrombocythemic": a molecular, histologic, and clinical study.
Rudzki Z; Sacha T; Stój A; Czekalska S; Wójcik M; Skotnicki AB; Grabowska B; Zduńczyk A; Okoń K; Stachura J
Int J Hematol; 2007 Aug; 86(2):130-6. PubMed ID: 17875526
[TBL] [Abstract][Full Text] [Related]
19. Advances in the molecular characterization of Philadelphia-negative chronic myeloproliferative disorders.
Pikman Y; Levine RL
Curr Opin Oncol; 2007 Nov; 19(6):628-34. PubMed ID: 17906464
[TBL] [Abstract][Full Text] [Related]
20. [Essential thrombocythemia. Contribution of the V617F JAK2 mutation to the pathophysiology, diagnosis and outcome].
Brière J
Bull Acad Natl Med; 2007 Mar; 191(3):535-48. PubMed ID: 18072652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]